All News

Traditional innovation has been about creating something new that an individual can pay for. That’s no longer enough, says Mats Williander.

On Tuesday, October 24, IBM filed in Texas federal court two suits for patent infringement against Amazon Inc. While details of five patents were not disclosed, one patent attracted particular interest: Patent US 5,319,542 - Ordering Items Using an Electronic Catalogue. Is it possible that IBM challenges the famous “one-click order” patent of Amazon? In any case, if the suit comes to trial, it will provide an opportunity to test not only the validity of this particular patent, but more generally of “business methods” patents, which have been highly controversial.

Big pharma is hungry, and is paying biotechs breathtaking prices to fill its pipelines. This made for a heady atmosphere at BioEurope in Düsseldorf this week.

A national network of 22 nanotechnology centres across the UK was formally launched last week with £50 million in government funding.

The head of Microsoft’s Cambridge lab outlines the strategy: to scout the science world for new software markets.

QinetiQ is leading a new consortium from industry, academia and the "UK defence supply chain" for MEMs Applications for Defence.

This time it is a major drugs company that is setting up its fume cupboards in China.